関連する実験動画
Updated: Sep 9, 2025

12:08
Diagonal Method to Measure Synergy Among Any Number of Drugs
Published on: June 21, 2018
18.8K
MOSAIC:パーソナライズドヘルスケアにおけるシナジスティックな薬物組み合わせを予測するための多粒度クロスモダルフレームワーク
IEEE journal of biomedical and health informatics
|September 4, 2025
まとめ
この研究では,分子および断片レベルの特徴を分析することによって,パーソナライズされたがん治療のためのシナージー薬の組み合わせを予測するAI方法であるMOSAICを導入します. MOSAICは 薬剤の発見と治療計画を強化し 重要なシナジェスティックな断片を特定します
科学分野:
- コンピュータ化学
- 薬剤開発における人工知能
- パーソナライズド医療
背景:
- パーソナライズされたがん治療は 効果的な薬の組み合わせに依存しています
- 合成薬の組み合わせを特定するには 計算手法が不可欠です
- 既存の方法は微細な分子相互作用分析が欠けている.
研究 の 目的:
- 合成薬の組み合わせを予測するためのAI駆動の方法を開発する.
- 多粒度分子特性を考慮して,パーソナライズされたがん治療を改善する.
- 薬剤の相乗効果を予測するための現在の計算方法の限界に対処する.
主な方法:
- MOSAICはグラフとSMILESのモダリティを持つ二層表現システムを使用しています.
- BRICSアルゴリズムは分子を断片に分解し,双方向のクロスアテンションで情報交換が可能になる.
- 対照的な学習は意味の一貫性を確保し,双線的および複数頭の注意は断片の相互作用を捕捉します.
主要な成果:
- MOSAICは 最先端の薬剤の組み合わせを 予測する上で優れています
- 文献の検証は,予測された組み合わせが臨床的証拠と一致することを確認した.
- ビジュアライゼーション分析は,薬剤のシナジーのための重要な分子断片を特定します.
結論:
- MOSAICは パーソナライズされたシナージー薬の組み合わせの予測に 新しいアプローチを提供します
- この方法は,がん治療の戦略を最適化するための洞察を提供します.
- MOSAICは 治療効果に不可欠な 重要な分子断片を特定するのに役立ちます
関連する概念動画
Combination Therapies and Personalized Medicine
5.1K
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
5.1K
Combined Effects of Drugs: Synergism
4.7K
Synergism is a useful mechanism where combining two or more drugs is more effective than each constituent used alone. Such combinations are also called supra-additive interactions. The drugs collectively enhance the final therapeutic effect by acting on different targets. Another advantage is that the low dose of each constituent drug is sufficient to achieve the desired effect. This helps reduce the duration of therapy and lower the adverse effects of these drugs.
Such synergistic combinations...
Such synergistic combinations...
4.7K
Agonism and Antagonism: Quantification
556
When drugs are administered, they can elicit either an agonist or antagonist effect on the body. Agonism occurs when a drug activates a specific receptor, triggering a biological response. On the other hand, antagonism happens when a drug binds to the same receptors but blocks their activation, thereby preventing a biological response.
To quantify these effects, researchers use a dose-response curve, which provides valuable information about the potency and efficacy of a drug. Potency refers to...
To quantify these effects, researchers use a dose-response curve, which provides valuable information about the potency and efficacy of a drug. Potency refers to...
556
Issues And Trends In Healthcare Delivery System
5.8K
The issues and trends in healthcare delivery are constantly changing. The COVID-19 pandemic is one recent issue that wreaked havoc on healthcare systems, causing a shortage of healthcare workers, high demand for medicines and supplies, and increased medical expenditure due to a lack of insurance. Other issues include rising healthcare costs and care fragmentation.
Cost Containment
Payment for healthcare services has historically promoted adoption of costly and often unnecessary or inefficient...
Cost Containment
Payment for healthcare services has historically promoted adoption of costly and often unnecessary or inefficient...
5.8K
Structure-Activity Relationships and Drug Design
1.0K
Drug design is a dynamic field that involves discovering and developing new medications based on specific biological targets. This process heavily relies on structure-activity relationships (SAR) and quantitative structure-activity relationships (QSAR) to guide the design and optimization of efficient drugs.
SAR studies the intricate relationship between a drug's chemical structure and biological activity. It focuses on understanding how modifications to a drug's structure can influence...
SAR studies the intricate relationship between a drug's chemical structure and biological activity. It focuses on understanding how modifications to a drug's structure can influence...
1.0K
Analysis of Population Pharmacokinetic Data
381
Analysis of population pharmacokinetic data involves studying the behavior of drugs within diverse populations to understand their pharmacokinetic parameters. Traditional pharmacokinetic methods typically involve collecting samples from a few individuals and estimating these parameters. While these methods are commonly used, they have limitations in capturing the variability in drug response among individuals or heterogeneous populations. Population pharmacokinetics is employed to address these...
381

